156 related articles for article (PubMed ID: 38667782)
1. Synthesis and Late-Stage Modification of (-)-Doliculide Derivatives Using Matteson's Homologation Approach.
Tost M; Kazmaier U
Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667782
[TBL] [Abstract][Full Text] [Related]
2. Total synthesis of apratoxin A and B using Matteson's homologation approach.
Andler O; Kazmaier U
Org Biomol Chem; 2021 Jun; 19(22):4866-4870. PubMed ID: 33998628
[TBL] [Abstract][Full Text] [Related]
3. (-)-Doliculide, a new macrocyclic depsipeptide enhancer of actin assembly.
Bai R; Covell DG; Liu C; Ghosh AK; Hamel E
J Biol Chem; 2002 Aug; 277(35):32165-71. PubMed ID: 12077149
[TBL] [Abstract][Full Text] [Related]
4. Total synthesis of (-)-doliculide, structure-activity relationship studies and its binding to F-actin.
Matcha K; Madduri AV; Roy S; Ziegler S; Waldmann H; Hirsch AK; Minnaard AJ
Chembiochem; 2012 Nov; 13(17):2537-48. PubMed ID: 23129522
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of actin-binding (-)-doliculide.
Foerster F; Braig S; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2014 Sep; 22(18):5117-22. PubMed ID: 24679674
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis of odoamide, a novel cyclic depsipeptide, from an Okinawan marine cyanobacterium.
Kaneda M; Sueyoshi K; Teruya T; Ohno H; Fujii N; Oishi S
Org Biomol Chem; 2016 Sep; 14(38):9093-9104. PubMed ID: 27722687
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of the cytotoxic cyclodepsipeptide (-)-doliculide: the "ester" effect in acyclic 1,3-induction of deoxypropionates.
Hanessian S; Mascitti V; Giroux S
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11996-2001. PubMed ID: 15210988
[TBL] [Abstract][Full Text] [Related]
8. "Head-to-side-chain" cyclodepsipeptides of marine origin.
Pelay-Gimeno M; Tulla-Puche J; Albericio F
Mar Drugs; 2013 May; 11(5):1693-717. PubMed ID: 23697952
[TBL] [Abstract][Full Text] [Related]
9. Actin-binding doliculide causes premature senescence in p53 wild type cells.
Foerster F; Chen T; Altmann KH; Vollmar AM
Bioorg Med Chem; 2016 Jan; 24(2):123-9. PubMed ID: 26692350
[TBL] [Abstract][Full Text] [Related]
10. Effective Synthesis and Antifouling Activity of Dolastatin 16 Derivatives.
Casalme LO; Katayama K; Hayakawa Y; Nakamura K; Yamauchi A; Nogata Y; Yoshimura E; Matsuda F; Umezawa T
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200652
[TBL] [Abstract][Full Text] [Related]
11. Mollemycin A: an antimalarial and antibacterial glyco-hexadepsipeptide-polyketide from an Australian marine-derived Streptomyces sp. (CMB-M0244).
Raju R; Khalil ZG; Piggott AM; Blumenthal A; Gardiner DL; Skinner-Adams TS; Capon RJ
Org Lett; 2014 Mar; 16(6):1716-9. PubMed ID: 24611932
[TBL] [Abstract][Full Text] [Related]
12. Total synthesis and biological activity of dolastatin 16.
Casalme LO; Yamauchi A; Sato A; Petitbois JG; Nogata Y; Yoshimura E; Okino T; Umezawa T; Matsuda F
Org Biomol Chem; 2017 Feb; 15(5):1140-1150. PubMed ID: 28074955
[TBL] [Abstract][Full Text] [Related]
13. Total Synthesis and Stereochemical Revision of Stereocalpin A: Mirror-Image Approach for Stereochemical Assignments of the Peptide-Polyketide Macrocycle.
Kaneda M; Inuki S; Ohno H; Oishi S
J Org Chem; 2018 Mar; 83(6):3047-3060. PubMed ID: 29470088
[TBL] [Abstract][Full Text] [Related]
14. Deorphaning the Macromolecular Targets of the Natural Anticancer Compound Doliculide.
Schneider G; Reker D; Chen T; Hauenstein K; Schneider P; Altmann KH
Angew Chem Int Ed Engl; 2016 Sep; 55(40):12408-11. PubMed ID: 27605391
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and novel structure-activity relationships of potent sansalvamide A derivatives.
Otrubova K; Styers TJ; Pan PS; Rodriguez R; McGuire KL; McAlpine SR
Chem Commun (Camb); 2006 Mar; (9):1033-4. PubMed ID: 16491200
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
[TBL] [Abstract][Full Text] [Related]
17. Total synthesis of verucopeptin, an inhibitor of hypoxia-inducible factor 1 (HIF-1).
Takahashi N; Hayashi H; Poznaks V; Kakeya H
Chem Commun (Camb); 2019 Oct; 55(79):11956-11959. PubMed ID: 31531455
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actin.
Tannert R; Milroy LG; Ellinger B; Hu TS; Arndt HD; Waldmann H
J Am Chem Soc; 2010 Mar; 132(9):3063-77. PubMed ID: 20148556
[TBL] [Abstract][Full Text] [Related]
19. Synthetic and pharmacological studies on new simplified analogues of the potent actin-targeting Jaspamide.
Terracciano S; Bruno I; D'Amico E; Bifulco G; Zampella A; Sepe V; Smith CD; Riccio R
Bioorg Med Chem; 2008 Jul; 16(13):6580-8. PubMed ID: 18508272
[TBL] [Abstract][Full Text] [Related]
20. Case studies of the synthesis of bioactive cyclodepsipeptide natural products.
Stolze SC; Kaiser M
Molecules; 2013 Jan; 18(2):1337-67. PubMed ID: 23348990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
